Date: 2017-03-21
Type of information: Nomination
Compound:
Company: Piqur Therapeutics (Switzerland)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On March 21, 2017, Piqur Therapeutics announced that it has strengthened its management team with the appointment of Dr. Melanie Rolli as Chief Medical Officer. She joins Piqur from Novartis Pharma, where she held various positions with increasing responsibilities over the last 14 years, most recently as Global Head Medical Safety. Prior to joining Novartis, she worked as a medical doctor at the University Hospital in Mannheim and as a basic researcher in academic settings in Germany and at the Scripps Research Institute, USA. PIQUR’s management team now consists of the following members: • Dr. Vladimir Cmiljanovic, Chief Executive Officer • Dr Melanie Rolli, Chief Medical Officer • Dr. Doriano Fabbro, Chief Scientific Officer • Hervé Girsault, Chief Business Officer
Financial terms:
Latest news:
